The determination of neuronal and glial fate during CNS development involves complex interactions of intrinsic signals through many transcription factors.^[@bib1]^ Neural stem cells (NSCs) have been considered as primary progenitor cells that lead to the formation of neuronal or glial cell lineages during development.^[@bib2]^ NSCs are multipotent stem cells that exist in prenatal and early postnatal stages in two zones, the ventricular zone (VZ) and the subventricular zone (SVZ).^[@bib3]^ NSCs develop into immediate progeny that are known as neural progenitor cells (NPCs),^[@bib4]^ which have limited self-renewal capacity, behave as transient amplifying cells and have a higher rate of differentiation compared with NSCs.^[@bib5]^

Growth and proliferation of NPCs require short-range autocrine/paracrine signals and the NPCs to be in close contact with one another. It has been suggested that one such short-range pathway is the ATP signaling. Purinergic receptors have been classified into two major families: P2Y and P2X receptors. Purinergic receptors have been shown to express in the early embryonic brain and have a role in embryogenesis.^[@bib6]^ ATP acts as a proliferation signal for NPCs and also as a negative regulator of terminal neuronal differentiation through P2Y receptors.^[@bib7]^ In addition, ATP has been shown to promote cell--cell communication and embryogenesis via stimulation of increases in intracellular Ca^2+^ concentration (\[Ca^2+^\]~i~).^[@bib8],\ [@bib9]^ ATP has also been found to enhance proliferation by elevating \[Ca^2+^\]~i~ in olfactory epithelium.^[@bib10]^ Thus, ATP-mediated Ca^2+^ signaling may have a crucial role in neurogenesis through regulation of differentiation, migration and cell fate determination.

Unlike other P2X receptor subtypes, the P2X~7~ receptor (P2X~7~R) has a short intracellular N-terminal domain, two transmembrane domains and a long C-terminal domain.^[@bib11]^ Activation of P2X~7~Rs is known to induce Ca^2+^ influx and gliotransmitter release in astrocytes.^[@bib12],\ [@bib13]^ Expression of P2X~7~Rs has been identified in neurons and activation of the receptor results in glutamate-mediated excitation.^[@bib14]^ P2X~7~Rs can be found in growth cones and can modulate neurotransmitter release in neurons.^[@bib15]^ Recent studies have shown that the inhibition of P2X~7~R improves recovery after spinal cord injury and promotes axonal growth in hippocampal neurons.^[@bib16],\ [@bib17]^ Thus, P2X~7~Rs may have an important role in neuronal growth and regeneration.

Although the transcriptional and epigenetic factors involved in determination of NPCs fate have been well characterized, P2X~7~R-mediated extracellular cues in NPCs remain unexamined. A previous report indicated that the expression of P2X~7~Rs was found from E14 onward in rat embryos and triggered Ca^2+^ wave in the VZ of E16 brain.^[@bib6],\ [@bib18]^ Adult NPCs have also been found to express P2X~7~Rs, and their stimulation evoked an inward current and membrane depolarization.^[@bib19]^ In this study we investigate the expression of P2X~7~Rs in E15, E18 and P4 rat brain, and examine the mechanism involved in the P2X~7~R-mediated neuronal differentiation of NPCs established from the E15.5 rat brain. We demonstrated that P2X~7~R is expressed in VZ and SVZ of the E15, E18 and P4 rat brain, and that stimulation of the receptors on the NPCs induces neuronal differentiation via the PKC-ERK1/2 signaling pathway.

Results
=======

P2X~7~R RNA is expressed in the developing rat brain
----------------------------------------------------

In the present study we examined the expression of P2X~7~R mRNA using *in situ* hybridization (ISH) and the expression of neuronal markers using immunohistochemistry (IHC). Our preliminary results revealed that P2X~7~R mRNA was predominantly expressed in the cerebral cortex, basal ganglia and thalamus in the E15.5 rat brain ([Supplementary Figure 1A](#sup1){ref-type="supplementary-material"}); therefore, we focused our analysis on these areas. As shown in [Figure 1a](#fig1){ref-type="fig"}, enrichment of P2X~7~R mRNA was observed in the VZ and SVZ of the E15.5 rat brain and colocalized with nestin expression in these areas. P2X~7~R mRNA expression was also found to colocalize with TUJ1 expression in the SVZ of the E15.5 brain ([Figure 1b](#fig1){ref-type="fig"}). However, in the E18.5 ([Figure 1c](#fig1){ref-type="fig"}) and P4 ([Figure 1d](#fig1){ref-type="fig"}) rat brains, few nestin-positive cells were observed to colocalize with P2X~7~R mRNA in the VZ. Furthermore, P2X~7~R mRNA colocalized with nestin in the E18.5 hippocampus ([Figure 1e](#fig1){ref-type="fig"}) and colocalized with TUJ1 in CA1 and CA3, as well as in the granule cell layer and subgranular zone (SGZ) of dentate gyrus (DG) in the hippocampus at P4 ([Figure 1f](#fig1){ref-type="fig"}). Higher-magnification microscopic analysis revealed that P2X~7~R mRNA expression was more abundant in the cortical cells of the P4 brain than that of E15.5 brain ([Figure 1g](#fig1){ref-type="fig"}). These results showed that P2X~7~R mRNA is generally expressed in nestin-positive NPCs in the developing rat brain. Our results further showed that P2X~7~R mRNA is also expressed in terminally differentiated neural cells at E18.5.

P2X~7~R negatively regulates NPC proliferation
----------------------------------------------

To further investigate the roles of P2X~7~Rs in VZ and SVZ, we established NPC cultures using cells isolated from the E15.5 rat brain. RT-PCR analysis revealed that these cells expressed P2X~7~R mRNA ([Figure 2a](#fig2){ref-type="fig"}). Ca^2+^ imaging analysis revealed that a potent P2X~7~R agonist, BzATP, stimulated increase in \[Ca^2+^\]~i~ ([Figure 2b](#fig2){ref-type="fig"}) that was abolished by the removal of Ca^2+^ in the medium and was inhibited by the selective P2X~7~R antagonists, A438079, oxidized ATP (oATP), Brilliant Blue G (BBG) and calmidazolium ([Figure 2c](#fig2){ref-type="fig"}). Thus, BzATP might stimulate Ca^2+^ influx through P2X~7~R. RT-PCR analysis indicated NPCs also express other P2 receptors and a higher concentration of ATP-stimulated increases in \[Ca^2+^\]~i~ ([Supplementary Figures 2A and B](#sup1){ref-type="supplementary-material"}). To ascertain that the BzATP did not activate other P2 receptors of NPCs, we measure Ca^2+^ response in the presence of P2X, P2X~4~R, P2Y~1~R, P2YR, and P2X~1--6~R antagonists, PPADS, 5BDBD, MRS2179, suramin and TNP-ATP respectively. The results revealed that only PPADS inhibited BzATP-stimulated Ca^2+^ signal ([Supplementary Figure 2C](#sup1){ref-type="supplementary-material"}). This demonstrated that BzATP only activates P2X~7~R in NPCs. In addition, treatment of the NPC cultures with BzATP (1--100 *μ*M) for 4 days decreased the cell number dose dependently ([Figure 2d](#fig2){ref-type="fig"}). The BzATP treatment also decreased 5-bromo-2′-deoxyuridine (BrdU) incorporation of the spheres, and the statistical analyses revealed this decrease was dose dependent ([Figure 2e](#fig2){ref-type="fig"}). We conducted TUNEL assays to investigate whether the decreases in BrdU incorporation might be due to cell death. BzATP did not induce cell death compared with the controls, suggesting that the reduction in cell number could not be attributed to apoptosis ([Supplementary Figure 3A](#sup1){ref-type="supplementary-material"}). Flow cytometry analysis further revealed that BzATP treatment had no effect on the sub-G1 phase ([Supplementary Figure 4A](#sup1){ref-type="supplementary-material"}) but altered cell cycle progression by decreasing cells in the G0/G1 and G2 phases, and increased the number of cells in the S phases of these cells ([Figure 2f](#fig2){ref-type="fig"}). Thus, activation of P2X~7~R induced a negative regulation of proliferation and might increase the neuronal differentiation of NPCs.

Stimulation of P2X~7~R enhances the neuronal differentiation of NPCs
--------------------------------------------------------------------

To examine whether the activation of P2X~7~R induces the neuronal differentiation of NPCs, we analyzed the BzATP-stimulated TUJ1 expression via western blot analysis. Our preliminary analysis revealed that BzATP treatment induced increases in the TUJ1 expression, and a statistically significant increase was observed at day 7 ([Figure 2g](#fig2){ref-type="fig"}). We therefore analyzed NPC and neuronal marker expression by treating NPCs with 50 *μ*M BzATP for 7 days. We first stained the dispersed naive NPCs for GFAP and nestin expression. As shown in [Figure 3a](#fig3){ref-type="fig"}, the dispersed NPCs stained intensely for GFAP and nestin, but much more weakly for TUJ1 and MAP2. Treatment of BzATP enhanced the expression of TUJ1 and MAP2 ([Figure 3b](#fig3){ref-type="fig"}). The BzATP-enhanced expression of TUJ1 and MAP2 was inhibited by the P2X~7~R antagonists, oATP ([Figure 3c](#fig3){ref-type="fig"}) and A438079 ([Figure 3d](#fig3){ref-type="fig"}). The statistical analysis showed that BzATP treatment decreased the numbers of nestin-positive cells and enhanced the TUJ1- and MAP2-positive cells, and its effects were significantly inhibited by A438079, oATP and BBG ([Figure 3e](#fig3){ref-type="fig"}). Furthermore, real-time PCR analysis confirmed that BzATP treatment decreased the mRNA expression of NPCs markers, such as Wnt7a, msi1 and GFAP, but enhanced the expression of neuronal cell markers, such as doublecortin and neuronal-specific enolase ([Figure 3f](#fig3){ref-type="fig"}). Thus, activation of P2X~7~Rs is likely to enhance neuronal differentiation of NPCs.

To determine whether P2X~7~R is involved in the neuronal differentiation of NPCs, we used an shRNA knockdown assay. Full-length P2X~7~R was cloned using mRNA isolated from the NPCs and expressed in HEK293T cells. The shRNAs, sR-1133 and sR-135, decreased the P2X~7~R mRNA expression in HEK293T-P2X~7~R cells ([Figure 4a](#fig4){ref-type="fig"}). The shRNAs were infected into NPCs, and we then examined the BzATP-stimulated Ca^2+^ signaling with Ca^2+^ imaging analysis. The statistical analysis of the Ca^2+^ signaling showed that sR1133 and sR-135, but not the scrambled shRNA, significantly blocked the BzATP-induced Ca^2+^ signaling ([Figure 4b](#fig4){ref-type="fig"}). We then used immunocytochemical (ICC) to examine the expression of cell markers in these cells. sR-1133 and sR-135, but not sR-Scramble or sR-LacZ, decreased TUJ1 and NeuN expression in the BzATP-treated NPCs and a concomitant increase in nestin and GFAP expression ([Figures 4c--f](#fig4){ref-type="fig"}). Thus, we concluded that activation of P2X~7~R is involved in neuronal differentiation of NPCs.

The PKC/ERK1/2 pathway regulates NPC differentiation mediated by P2X~7~R
------------------------------------------------------------------------

It is known that the stimulation of P2X~7~R induces Ca^2+^ influx^[@bib20],\ [@bib21]^ and the activation of the Ca^2+^-dependent PKC and ERK1/2.^[@bib12],\ [@bib22]^ In the present study, the time-course analysis revealed that BzATP triggered a rapid ERK1/2 activation that peaked at 3 min and returned to base line levels at 15 min ([Figure 5a](#fig5){ref-type="fig"}). The statistical analysis revealed that BzATP triggered a 10-fold increase in p-ERK1/2 ([Figure 5b](#fig5){ref-type="fig"}). This effect was blocked by removal of extracellular Ca^2+^ and A438079 ([Figures 5c and d](#fig5){ref-type="fig"}). To further examine the components of upstream signaling in ERK1/2 activation, we inhibited MEK, CaMKII, PKC and PI3K, with PD98059, KN93, GF109203X and LY294002, respectively. As shown in [Figure 5e](#fig5){ref-type="fig"}, p-ERK1/2 was inhibited by GF109203X and PD98059, but not by KN93 or LY294002. The statistical analysis demonstrated that PD98059 and GF109203X significantly inhibited the BzATP-stimulated ERK1/2 activation ([Figure 5f](#fig5){ref-type="fig"}). Together, these results indicated PKC and MEK, but not CaMKII or PI3K, are involved in the P2X~7~R-mediated ERK1/2 activation, and Ca^2+^-dependent PKC isozymes may be the upstream signaling to ERK1/2.

We next examined the BzATP-induced translocation of the Ca^2+^-dependent PKC subtypes. BzATP stimulated increases in the membrane fractions of PKC*α* and PKC*γ* but not PKC*β* in NPCs ([Figure 6a](#fig6){ref-type="fig"}). The statistical analysis revealed that BzATP decreased PKC*α* and PKC*γ* but not the PKC*β* expression in the cytosolic fraction ([Figure 6b](#fig6){ref-type="fig"}), with concomitant increase in membrane fraction ([Figure 6c](#fig6){ref-type="fig"}). To ascertain whether PKC*α* and PKC*γ* are involved in the ERK1/2 signaling pathway, we used an shRNA knockdown assay. sR-PKC*α* and sR-PKC*γ* decreased the expression of PKC*α* and PKC*γ*, respectively ([Figure 6d](#fig6){ref-type="fig"}). The statistical analysis revealed that sR-PKC*α* and sR-PKC*γ* blocked an ∼70 and 60% of ERK activation, respectively ([Figure 6e](#fig6){ref-type="fig"}). Thus, both PKC*α* and PKCγ were involved in P2X~7~R-mediated activation of ERK. To confirm that PKC and ERK1/2 signaling cascade is involved in P2X~7~R-mediated neuronal differentiation of NPCs, the NPCs were treated with BzATP for 7 days and the number of TUJ1-positive cells was counted. Treatment with either GF109203X or PD98059 partially blocked the BzATP-induced increase in TUJ1-positive cells and increased the number of GFAP-positive cells ([Figure 7a](#fig7){ref-type="fig"}). The statistical analysis revealed that effects of PD98059 and GF109203X on BzATP-induced changes in TUJ1 and GFAP expression were significant ([Figure 7b](#fig7){ref-type="fig"}). Thus, PKC-ERK1/2 signaling is involved in P2X~7~R-mediated the neuronal differentiation of NPCs.

Discussion
==========

A previous study showed that P2X~7~R mRNA is expressed from E14 onward in the rat brain.^[@bib6]^ Similarly, we observed that P2X~7~R mRNA is expressed in the VZ and SVZ of the E15.5 rat brain. By using the E15.5 brain-derived NPC cultures, we further demonstrated that the potent P2X~7~R agonist BzATP stimulated Ca^2+^ signaling and induced the neuronal differentiation of these cells. Thus, functional P2X~7~Rs are expressed in NPC-enriched areas of the embryonic brain.

During development, neuronal differentiation begins at E11.5, peaks at ∼E14 and continues at lower levels until E17.5.^[@bib23]^ Our data showed that P2X~7~R mRNA was expressed in the proliferating NPCs of the VZ and SVZ of the E15.5 rat brain. As development proceeded, the P2X~7~R-expressing differentiating cells moved outwards through the intermediate zone to the cortical plate area. A high level of P2X~7~R mRNA was observed in the cortical plate area, possibly due to rapid increases in P2X~7~R-expressing glial cells *in vivo* starting at E17 ([Supplementary Figure 1B](#sup1){ref-type="supplementary-material"}). However, P2X~7~R mRNA was also observed in the SVZ and VZ, and throughout the layers of the hippocampus, including the CA1 and CA3 regions, and the SGZ of DG at P4. In adulthood, there is continuous production of new neurons that migrate from the SGZ to the adjacent granule cell layer of the DG.^[@bib24]^ Our results showed the presence of P2X~7~R mRNA in the DG from E18.5 to adulthood and P2X~7~R mRNA colocalized with a marker of immature neurons. This suggests that P2X~7~R expression may be associated with neuronal growth from embryonic stages through adulthood. Recently, P2X~7~R mRNA was found to be expressed in neurons of the adult rat hippocampus to regulate neurotransmitter release.^[@bib25]^ Our results are consistent with the findings that P2X~7~Rs are expressed in neurons in the hippocampal area and other regions of the brain.^[@bib14],\ [@bib17],\ [@bib26],\ [@bib27]^

ATP signaling has been shown to occur during development, both at early stages, such as gastrulation and germ layer definition, and in the late stages of neural development.^[@bib28],\ [@bib29]^ P2X~7~R expression was initially identified in glial cells in the CNS^[@bib20],\ [@bib30],\ [@bib31]^ and was functionally linked to cytokines and gliotransmitter release.^[@bib12],\ [@bib32]^ Our group showed that P2X~7~R is involved in proliferation, whereas inhibition and knockdown of the receptor induced neuronal differentiation of N2a neuroblastoma cells.^[@bib33]^ It is known that activation of P2X~7~R induces a sustained increase in \[Ca^2+^\]~i~ through Ca^2+^ influx. Therefore, P2X~7~R may act as a mechanism to regulate \[Ca^2+^\]~i~ and control a diverse range of Ca^2+^-mediated cellular functions. Until now, the roles of cellular ATP signaling and P2X~7~R in NPCs have remained unexamined. It has been shown that ATP release via hemichannels in retinal pigment epithelium evoked spontaneous elevations of \[Ca^2+^\]~i~ in retinal progenitor cells and in the developing brain.^[@bib9],\ [@bib29]^ Therefore, ATP release may act as an autocrine signal to activate P2X~7~R and induce Ca^2+^ influx, altering cellular function during development.

It is accepted that ATP is a neurotransmitter in the both central and peripheral nervous systems. ATP is also known to act as a regulator in glia-neuron communication and regulate synaptic transmission and plasticity.^[@bib34]^ ATP is released from nerve terminals via exocytosis and from non-neuronal cells via various mechanisms.^[@bib35]^ Presumably, ATP may be released from the NPCs or the neighboring cells to activate P2X~7~R and other purinergic receptors during development. Our preliminary results showed that NPCs possess several purinergic receptors and that ATP stimulated increases in \[Ca^2+^\]~i~ in these cells ([Supplementary Figures 5A and B](#sup1){ref-type="supplementary-material"}). Therefore, ATP might activate signaling downstream of Ca^2+^ influx, perhaps through the conventional PKC isozymes in NPCs.

PKC isozymes have been shown to act as upstream regulators of MAPKs.^[@bib36],\ [@bib37]^ Our early results have shown that the stimulation of P2X~7~R activated PKC and ERK1/2^[@bib12],\ [@bib30]^ and induced the interaction of PKCγ with P2X~7~R in astrocytes.^[@bib38]^ Similarly, we found that stimulation of P2X~7~R activated the conventional PKC isozymes PKC*α* and PKC*γ*, but not PKC*β*, and also activated ERK1/2, but not PI3K and CAMKII, in NPCs. Stimulation of P2X~7~R was shown to activate a CAMKII-related pathway and to negatively regulate axon^[@bib17]^ and neurite growth.^[@bib39]^ Recently, stimulation of P2X~7~R induced translocation of PKC-*β*1 in mouse alveolar epithelial E10 cells.^[@bib40]^ Thus, activation of P2X~7~R may also activate different intracellular signaling mechanisms to regulate distinct cellular functions in various types of cells.

Prolonged stimulation of P2X~7~R induces the formation of a non-selective pore and leads to cell death.^[@bib41],\ [@bib42]^ The stimulation of P2X~7~R in E14.5 NPCs induced cell death in the absence of pore formation.^[@bib43]^ In the present study, the stimulation of P2X~7~R in E15.5 NPCs triggered neither pore formation nor cell death but did induce neuronal differentiation ([Supplementary Figure 5](#sup1){ref-type="supplementary-material"}). P2X~7~R was identified to have survival- and growth-promoting effects in certain cancer cells.^[@bib44]^ In contrast, our earlier result demonstrated that inhibition or knockdown of P2X~7~R induced neuronal differentiation of N2a neuroblastoma cells.^[@bib33]^ The stimulation of the P2X~7~R-expressing HEK293 cells increased cell survival in serum-free conditions.^[@bib45]^ Thus, stimulation of P2X~7~R may lead to alterations of different physiological functions in different types of cells. This specificity may also be due to different isoforms of P2X~7~R. Several single-nucleotide polymorphisms with alterations in pathophysiological functions have been identified in human P2X~7~Rs.^[@bib46],\ [@bib47]^ At least two splice variant isoforms have been identified in mice.^[@bib48],\ [@bib49]^ The P2X~7~ (k) variant was identified to be constitutively dilated and highly sensitive to agonist BzATP, and escaped gene deletion in one of the P2X~7~R knockout mouse strains.^[@bib48]^ A recent report also indicated that the ΔC variant is inefficiently trafficked to the cell surface and has little agonist-evoked current.^[@bib50]^ Thus, there are apparent functional and physiological differences between the wild-type receptor and the variants. It is possible that the rat E15.5 NPCs express more than one P2X~7~R isoform. Further identification of P2X~7~R isoforms and their physiological functions in NPCs are needed.

NPCs transplantation has been used to deliver therapeutic genes directly to the mouse brain to correct metabolic diseases.^[@bib51]^ The present study not only provides a system to understand the role of P2X~7~R in brain development but also identifies a signaling pathway with possible therapeutic target sites.

Materials and Methods
=====================

Animal tissue preparation
-------------------------

All the experimental animals were approved by the laboratory animal center of the National Yang Ming University (Taipei, Taiwan). The pups were perfused with 0.9% NaCl, followed by fixation with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). The brains were dissected, post-fixed with the same fixative solution for 8 h at 4 °C and then dehydrated in 30% sucrose at 4 °C overnight. All solutions were sterile-filtered and treated with 0.1% diethyl pyrocarbonate. Brain sections were cut into 10-*μ*m slices with a Leica 3050S (Leica Biosystems, Wetzlar, Germany) and were stored at −80 °C until use. For each experiment, at least three animals were used for each development stage.

Isolation and propagation of embryonic NPCs
-------------------------------------------

Embryonic NPCs were grown according to the method described previously, with modifications.^[@bib52]^ Cells were dissociated from the midbrain and telencephalon without striatum of the E15.5 Sprague--Dawley rat brain and cultured in DMEM/F12 supplemented with N2 (Life Technologies, Frederick, MD, USA),^[@bib53]^ epidermal growth factor (20 ng/ml), basic fibroblast growth factor (10 ng/ml; PeproTech, Rocky Hill, NJ, USA), heparin (5 *μ*g/ml; Sigma-Aldrich, St. Louis, MO, USA) and 50 U/ml penicillin. Neurospheres appeared after 1 week in culture. Medium was replaced every 3 days with gentle trituration, and the spheres were further cultured for 1 month. The cultures were then stained with nestin for the identification of NPCs; 95% of the cells were nestin-positive. After treatment with BzATP (0, 1, 10, 25, 50 and 100 *μ*M) for 4 days, the spheres were mechanically dissociated into single cell, mixed with 0.1% Trypan Blue solution (1:1) and counted immediately with a hemocytometer.

*In vitro* differentiation, cell cycle progress and cell death assay
--------------------------------------------------------------------

To induce differentiation, cells were cultured in DMEM/F12 supplemented with N2 supplement and 0.5% FBS for 2 days.^[@bib54],\ [@bib55]^ Then, fresh differentiation medium with P2X~7~R agonist, BzATP, was provided for 7 days. To assay for cell cycle progression, neurospheres were dissociated into single-cell suspension and were fixed in 70% (v/v) ethanol at 4 °C for 1.5 h, washed twice with PBS and were stained with propidium iodide (PI) solution (50 *μ*M ribonuclease A, 4 *μ*M PI, 0.1% Triton X-100 in PBS) for 30 min in the dark. Then, cells were assayed with a flow cytometer (FACSCalibur; BD Biosciences, San Diego, CA, USA) and the results were analyzed using FCS Express software (*De Novo* Software, Los Angeles, CA, USA). To assay for cell death, cells were fixed with PFA and analyzed for TUNEL-stained nuclei using a TUNEL kit (Roche, Basel, Switzerland) according to the manufacturer\'s instructions.

Immunofluorescence staining
---------------------------

For IHC staining, brain sections were treated with 0.1% Triton X-100 in PBS for 20 min, incubated in PBS containing 2% goat serum and 3% horse serum for 1 h, and then incubated with primary antibodies in blocking solution at 4 °C overnight. An ICC analysis was also performed by fixing NPCs in 4% PFA for 20 min, treating with 0.1% Triton X-100 in PBS for 20 min and incubating with primary antibodies at 4 °C overnight before incubation in blocking solution for 1 h. After rinsing three times, the sections or cells were incubated with secondary antibodies conjugated to fluorescein and Texas red (1:200; all from Vector Laboratories) for 2 h and then incubated with 4′-6-diamidino-2-phenylindole (DAPI) for 15 min. Fluorescence signals were detected with a FV300 confocal imaging system (Olympus Japan, Tokyo, Japan). Cell numbers were quantified using NIH ImageJ software. Primary antibodies and dilutions were as follows: GFAP (1:1000; DAKO, Glostrup, Denmark), Nestin (1:200; Millipore, Bedford, MA, USA), NeuN (1:200; Chemicom, Temecula, CA, USA), MAP2 (1:300; Chemicom) and β-tubulin type III monoclonal (TUJ1, 1:1000; Promega, Southampton, UK).

*In vitro* transcription
------------------------

The P2X~7~R probe was cloned into pGEM T-easy vector (Promega) for the antisense and sense riboprobe synthesis. The non-radioactive riboprobes were synthesized by *in vitro* transcription using T7 and SP6 polymerase (Promega), respectively, and were labeled with digoxigenin-labeling mix (Roche). Before hybridization, the riboprobes were diluted with the hybridization buffer to 2 ng/*μ*l and denatured at 65 °C for 10 min. A 119 bp cDNA fragment of the P2X~7~R corresponds to bases from 1258 to 1376 (numbering a according to GenBank accession number no. X95882).

ISH of P2X~7~R mRNA expression
------------------------------

Brain sections were fixed with 4% PFA, treated with 0.2 N HCl and l *μ*g/ml protease K, and then incubated with prehybridization buffer containing 50% formamide and 2 × SSC at 60 °C for 90 min. The sections were hybridized with digoxigenin-labeled riboprobes in hybridization buffer (10% dextran sulfate, 50% formamide, 1 mM EDTA, 318 mM NaCl, 10.6 mM Tris, 1 × Denhardt\'s solution, 500 *μ*g/ml tRNA and 10 mM DTT) at 60 °C for 16 h, washed with 50% formamide in 2 × SSC at 60 °C for 1 h, 20 *μ*g/ml RNaseA for 30 min, and then washed sequentially with 2 × SSC and 0.2 × SSC at 60 °C for 20 min. The sections were blocked with 2% blocking reagent containing 8% sheep serum in TNT buffer (100 mM Tris, pH 7.5, 150 mM NaCl and 0.05% Tween-20) for 1 h. The endogenous peroxidases were inhibited with 0.3% H~2~O~2~ in PBS for 10 min and the sections were then incubated with POD-conjugated sheep anti-digoxigenin antibody (1:1000, Roche) for 3 h. After washing with TNT buffer twice, the signals were detected by using TSA PLUS Fluorescence Kits (1:700, PerkinElmer, Norwalk, CT, USA).

Protein fractionation, immunohistology analysis and western blot
----------------------------------------------------------------

For western blot analysis, proteins were extracted by scraping the NPCs in homogenate buffer (320 mM sucrose, 1 mM EDTA, 50 mM Tris-HCl, 1 mM PMSF and 1 × proteinase inhibitor). After homogenation on ice, cell lysates were cleared by centrifugation at 1000 × *g* in a microcentrifuge (Kubota, Tokyo, Japan) for 10 min at 4 °C. The supernatant were then centrifuged at 100 000 × *g* in a desktop ultracentrifuger (Beckman Coulter, Fullerton, CA, USA). The cytosolic fraction was taken from the supernatants after centrifugation and the membrane fraction from the pellets was lysed in lysis buffer (20 mM HEPES, 1% Triton X-100, 10 mM NaF, 1 mM Na~3~VO~4~, 1 mM PMSF). Aliquots of proteins (20 *μ*g) proteins were separated by 10% SDS-PAGE, transferred onto PVDF membrane and incubated overnight with 5% BSA in PBS. The membranes were incubated with primary antibodies, followed by hybridized with the HRP-conjugated secondary antibody (1:10000; Vector Laboratories). The membranes were reacted with Luminata Western HRP Substrates (Millipore) and detected with a digital image system (ImageQuant LAS 4000; Fujifilm Lifescience, Tokyo, Japan). The primary antibodies contained phospho-p44/42 MAPK (p-ERK1/2; 1:400), p44/42 MAPK (ERK1/2; 1:200) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 1:1000), purchased from Cell Signaling Technology (Danvers, MA, USA). PKC*α* (1:500), PKC*β* (1:250), PKC*γ* (1:500) and flotillin (1:1000) antibodies were purchased from BD Biosciences.

Reverse-transcription PCR
-------------------------

Total RNA was extracted from NPCs with 1 ml of Rezol reagent (Protech Technologies, Taipei, Taiwan). One milligram of total RNA was reverse-transcribed using Superscript III reverse transcriptase (Life Technologies) in 20 *μ*l at 42 °C for 1 h according to the manufacturer\'s protocol. Primer 3 software (<http://frodo.wi.mit.edu>) was used to design oligonucleotide primers spanning intron sequences, and these primers are listed in [Table 1](#tbl1){ref-type="table"}.

Quantitative real-time PCR
--------------------------

Real-time PCR analyses were performed on the Rotor-Gene 3000 (Qiagen, Valencia, CA, USA) using the SYBR Fast One-Step qRT-PCR Kit (Kapa Biosystems, Woburn, MA, USA) and the manufacturer\'s protocol. Specific primers were designed by Primers 3 software and are listed in [Table 1](#sup1){ref-type="supplementary-material"}. The melting curve detected a single melt peak and PCR efficiency values between 90 and 110% for all amplicons. Relative gene expression levels were then normalized to GAPDH expression in each sample.

BrdU incorporation assay
------------------------

The BrdU incorporation assay was performed by using the Cell Proliferation BrdU kit (Roche). After the experiment, the cells were labeled with a 10 mM BrdU solution and incubated for 8 h at 37 °C, washed with PBS, fixed with FixDenat for 30 min and incubated in 1 N HCl for 10 min at 4 °C. The cells were then washed with PBS with 1% Triton X-100, neutralized with 0.1 M Na~2~B~4~O~7~ for 12 min and then blocked with 2% goat serum for 1 h. After rinsing with PBS, the cells were incubated with anti-BrdU-POD antibody (1:300) for 2 h, and the signals were detected with TSA PLUS Fluorescence kits.

Construction of expression plasmids
-----------------------------------

The pGEM-P2X~7~ plasmid was constructed by inserting the full fragment of the rat P2X~7~R sequence (number X95882) into the pGEM-T Easy vector (Promega). The primer is listed in [Table 1](#tbl1){ref-type="table"}. The fragments were generated by HiFi DNA polymerase (Yeastern Biotech, Shijr, Taiwan). The conditions were as follows: denaturation at 94 °C for 1 min followed by 30 cycles of denaturation at 94 °C for 15 s, annealing at 60 °C for 30 s and extension at 68 °C for 2 min followed by at 68 °C for 5 min. The products were cloned into a pGEM T-easy vector, and then the plasmid DNA was transfected into HEK293T cells with the Lipofectamine 2000 transfection method according to the manufacturer\'s procedure (Life Technologies). HEK293T cells were grown in DMEM (Life Technologies) medium with 10% FBS.

shRNA knockdown
---------------

shRNA targeting P2X~7~R mRNA was purchased from Biosettia (San Diego, CA, USA). The sequences are as follows: non-specific shRNA (sR-LacZ) 5′-GCAGTTATCTGGAAGATCAGG-CCTGATCTTCCAGATAACTGC-3′, sh-P2X~7~--135 (sR-135) 5′-GCAGCTGGAACGATGTCTTTC-GAAAGACATCGTTCCAGCTGC-3′, sh-P2X~7~--1133 (sR-1133) 5′-GGATCCACCCTGTCCTATTTC-GAAATAGGACAGGGTGGATCC-3′ and sh-P2X~7~-scramble shRNA (sR-Scramble) 5′-GCTACACTATCGAGCAATT-AATTGCTCGATAGTGTAGC-3′. All shRNA sequences have 5′-TTGGATCCAA-3′ in the sequence for the short-hairpin loop. The pLV-RNAi vector contains a mouse U6 promoter-driven shRNA coding sequence followed by a CMV-driven EGFP reporter. HEK293T cells expressing pGEM-P2X~7~ plasmid or NPCs were infected with sR-Scramble, sR-1133, sR-LacZ or sR-135, and the desired virus titer was reached when cells were infected at an MOI of 0.5. PKC*α* and PKC*γ* shRNA clones were obtained from the National RNAi Core Facility (Genomics Research Center, Academia Sinica, Taiwan). shRNA against the target sequence was sR-PKC*α* for mouse PKC*α* (clone ID TRCN0000235973) and sR-PKC*γ* for human PKC*γ* (TRCN0000199230).

Ca^2+^ image analysis
---------------------

Cells were grown on 24-mm coverslips and were incubated with loading buffer (125 mM NaCl, 5 mM KCl, 1.8 mM CaCl~2~, 2 mM MgCl~2~, 0.5 mM NaH~2~PO~4~, 5 mM NaHCO~3~, 10 mM HEPES and 10 mM glucose, pH 7.4) containing 1 *μ*g/ml Fura-2 AM (Life Technologies) for 40 min at 37 °C in the dark. Ca^2+^ imaging analysis was performed using excitation wavelengths (340/380 nm) selected by means of a computer-controlled rotating filter wheel between a xenon light source and the microscope. The resulting image at each wavelength was averaged in real time, digitalized and stored in an image-processing unit. The results were calculated using a Metafluor image analysis system (Universal Imaging Corporation, Philadelphia, PA, USA). Statistical analysis was conducted after the calculation of changes in fluorescence (ΔF) and expressed as percentage of the average baseline fluorescence (F) (%ΔF/F).^[@bib56]^

Statistical analysis
--------------------

All statistical analyses were performed using SAS Version 9.1.3 (SAS Institute, Cary, NC, USA) and SigmaPlot XII Software (Systat Software, San Jose, CA, USA). Results are represented as the mean±S.D. and the symbol \* indicates significantly different means (*P*\<0.05) as analyzed by a nonpaired Student\'s *t*-test or one-way ANOVA with Bonferroni\'s *post-hoc* test. The Mann--Whitney\'s *U*-test with nonparametric distribution was used to compare peak values of Ca^2+^.
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![Embryonic rat brain expresses P2X~7~R. Photomicrographs of the coronal sections of the SVZ and hippocampus were taken at different developmental stages, and were stained with ISH for P2X~7~R mRNA and with IHC for the cell markers nestin and TUJ1. E15.5 embryonic brains were stained for P2X~7~R (green) and nestin (red) (**a**), and for P2X~7~R (green) and TUJ1 (red) (**b**); SVZ, subventricular zone; VZ, ventricular zone; LV, lateral ventricle. The SVZ and VZ in the E18 (**c**) and P4 (**d**) rat brain were stained for P2X~7~R (green) and nestin (red). Scale bar: 100 *μ*M. The CA1-CA3 and DG of the hippocampus at E18.5 (**e**) and P4 (**f**) rat brain were stained for P2X~7~R (green) and nestin (red). Scale bar: 200 *μ*M; DG, dentate gyrus. (**g**) Higher-magnification photomicrographs of ISH for antisense P2X~7~R probe were stained in the cortical plate of the E15.5, E18.5 and P4 brains, and for the sense P2X~7~R probe at P4 brains. Scale bar: 20 *μ*M](cddis2013274f1){#fig1}

![Stimulation of P2X~7~R inhibits proliferation and alters cell cycle progression but does not cause cell death in NPCs. (**a**) RT-PCR analysis of P2X~7~R mRNA expression in NPCs and E15 rat brain. (**b**) The NPCs were loaded with fura-2 AM and stimulated with BzATP. The bold line represents an averaged trace of the Ca^2+^ signal (*n*=11). (**c**) \[Ca^2+^\]~i~ was calculated by subtracting the peak level from the basal level with (+) or without (−) extracellular Ca^2+^ or the P2X~7~ antagonists, 20 *μ*M A438079, 10 *μ*M oATP, 1 *μ*M BBG or 5 *μ*M calmidazolium (CMZ, *n*=5). \*Significantly different means (*P*\<0.05) using Mann--Whitney\'s *U*-test for comparison with BzATP. (**d**) BzATP dose-dependently affects the number of NPCs. The dissociated cells were treated with 1--100 *μ*M BzATP for 4 days and were counted by a hemocytometer (*n*=3). \**P*\<0.05 using Bonferroni\'s post test for comparison with the respective controls. (**e**) Photomicrographs of NPCs incubated in the presence or absence of BzATP for 4 days, labeled with BrdU for 8 h, counter-stained with DAPI and imaged. The results represent BrdU-positive cell percentages of total cells. (**f**) NPCs were treated with BzATP for 4 days and then labeled with PI, and the number of cells in each stage of the cell cycle was analyzed by flow cytometry. Comparison of results and statistical analysis (*n*=3). \**P*\<0.05 using nonpaired Student\'s *t*-test for comparison with the respective controls. (**g**) NPCs were analyzed by western blot analysis for TUJ1 expression after treatment with BzATP (0, 3, 5 and 7 days). Quantitative analyses represent percentages of TUJ1-expression to actin. Actin (1:2000) was purchased from Life Technologies. \**P*\<0.05 using Bonferroni\'s post test for comparison with the respective controls](cddis2013274f2){#fig2}

![Activation of P2X~7~R induces the neuronal differentiation of NPCs *in vitro*. Naive (**a**), BzATP-treated (**b**), BzATP +oATP-treated (**c**) and BzATP+A438079-treated (**d**) NPCs were double-stained for TUJ1 (green) and GFAP (red), or nestin (green) and MAP2 (red), and cell nuclei were counterstained with DAPI (blue). Photomicrographs were taken on a confocal microscope (*n*=5). Scale bar: 10 *μ*M. (**e**) The cells expressing the indicated marker protein and the DAPI-stained cells were counted and were analyzed statistically in the presence of oATP, A438079 or BBG. (**f**) Total RNA of NPCs was isolated, and quantitative RT-PCR analyses were performed to detect mRNA levels of msi1, Wnt7A, GFAP, doublecortin (DCX) or neuronal-specific enolase (NSE) expression in cells treated with or without BzATP. The mRNA transcripts were normalized to the controls (*n*=3). \**P*\<0.05 using nonpaired Student\'s *t*-test for comparison with the respective controls](cddis2013274f3){#fig3}

![Knockdown of P2X~7~R decreases agonist-stimulated neuronal differentiation. (**a**) The lenti-packaged shRNAs, sR-1133, sR-135, sR-Scramble or sR-Laz were infected into HEK293T- or P2X~7~R-expressing HEK293T (+P2X~7~R) cells. Total RNA was isolated and RT-PCR analysis was conducted (*n*=3); P2X~7~R expressed 293T cells. (**b**) Quantitative analyses of BzATP-stimulated \[Ca^2+^\]~i~ in cells infected with sR-1133, sR-135 or sR-Scramble (*n*=3). \**P*\<0.05 using Mann--Whitney *U*-test for comparison with BzATP. NPCs were infected with sR-1133 (**c**), sR-135 (**d**), sR-LacZ (**e**) or sR-Scramble (**f**), and treated with or without BzATP. The expression of neuronal or NPC markers was examined by ICC (*n*=3). \**P*\<0.05 using nonpaired Student\'s *t*-test for comparison with the respective controls](cddis2013274f4){#fig4}

![Stimulation of P2X~7~R activates an ERK1/2 and PKC signaling pathway in NPCs. (**a** and **b**) NPCs were incubated with 50 *μ*M BzATP for 0, 3, 7, 15, 30 and 60 min, and ERK1/2 activation was detected by western blot analysis (*n*=3). \**P*\<0.05 using Bonferroni\'s post test for comparison with the respective controls. Cells were pretreated with 10 *μ*M A438079, 4 mM EGTA (**c**), 10 *μ*M PD98059, 1 *μ*M KN93, 1 *μ*M GF109203X or 10 *μ*M LY294002 (**e**) for 30 min, and were examined for p-ERK1/2 by western blot analysis (*n*=3). \**P*\<0.05 using nonpaired Student\'s *t*-test for comparison with BzATP (**d**--**f**); Calcium free (EGTA), calcium chelator; GF, PKC inhibitor GF109203X; KN, CaMKII inhibitor KN93; LY, PI3K inhibitor LY294002; PD, MEK inhibitor PD98059](cddis2013274f5){#fig5}

![PKC*α* and PKCγ are associated with P2X~7~R-mediated ERK1/2 activation in NPCs. (**a**--**c**) NPCs were stimulated with BzATP, and cytosol and membrane fractions were isolated by centrifugation. The expression of Ca^2+^-dependent conventional PKC isozymes, PKC*α*, PKC*β* and PKCγ, of both membrane and cytosol fractions, was examined by western blot analysis (*n*=3). \**P*\<0.05 using nonpaired Student\'s *t*-test for comparison with the control. (**d**) NPCs were infected with Lenti-packaged shRNAs, sR-PKC*α* or sR-PKC*γ*, stimulated with BzATP for 3 min and examined for p-ERK1/2 levels by western blot analysis. (**e**) The ration of p-ERK1/2/ERK1/2 were calculated, using nonpaired Student\'s *t*-test for comparison with the BzATP (*n*=3)](cddis2013274f6){#fig6}

![A PKC-ERK signaling pathway is involved in P2X~7~R-mediated neuronal differentiation of NPCs. (**a**) NPCs were untreated or treated with BzATP, BzATP+PD98059 or BzATP+GF109203X for 7 days, and were then double-stained for GFAP (red) and TUJ1 (green). Cell nuclei were counterstained with DAPI; PD, MEK inhibitor PD98059; GF, PKC inhibitor GF109203X. Scale bar: 10 *μ*M. (**b**) The ratios of fluorescence-positive cells to the DAPI-stained cells per field were measured and are shown as change relative to total cells (*n*=3). ^&^*P*\<0.05, as compared with control for TUJ1 positive cells. \**P*\<0.05, as compared with BzATP for GFAP positive cells. (**c**) Schematic drawing of a model for P2X~7~R activation influence on neuronal differentiation of the NPCs. P2X~7~R is highly expressed in the membrane of NPCs and its activation triggers Ca^2+^ influx. The uptake of \[Ca^2+^\]~i~ into NPCs activates p-ERK1/2 through the translocation of PKC from the cytosol to membrane, and p-ERK1/2 induces neuronal differentiation](cddis2013274f7){#fig7}

###### Cell markers and purinergic receptor primers used for RT-PCR and Q-PCR analysis

  **Gene**       **Forward primer (5′--3′)**   **Reverse primer (5′--3′)**   **Product length (bp)**
  -------------- ----------------------------- ----------------------------- -------------------------
  *Gfap*         GACTTTCTCCAACCTCCAG           TCTCCACCGTCTTTACCA            98
  *Dcx*          GCAGTCAGCTCTCAACAC            GACAGTGGCAGGTACAAG            100
  *Gapdh*        ACTCCCATTCTTCCACCT            CATGTAGGCCATGAGGTC            128
  *Msi1*         GGTTACACCTACCAGTTCCC          GCCATCGGACCATAAGCA            110
  *Wnt7a*        CTTCGCCAAGGTCTTCGT            ACTCCAGTTTCATGTTCTCCTC        116
  *NSE*          GAACTATCCTGTGGTCTCC           CGACATTGGCTGTGAACTTG          80
  *P2rx7* full   ATACGGACCGATGCCGGCTTGC        CGGACCGTCAGTAGGGATACTTGAAG    1805
  *P2rx1*        GGGATTGGCATCTTTGGAG           CCCATGTCCTCGGCATATT           113
  *P2rx2*        CAGTCTCATTCCCACCATC           GTCACAGGCCATCTACTTGA          174
  *P2rx3*        GCACTGTTCTCTGTGACATC          CTGTAGACTGCTTCTCCACA          162
  *P2rx4*        GCTGGGAAGTTTGACATC            TGCAGTAGAGGACTATGACG          103
  *P2rx5*        CCAATGTTGAGGTTGAGG            CTACGTCTTCACTGGATGC           221
  *P2rx6*        GTCACCTTCCTCTGTGATCT          GTTGGTAGTTGCCTTTGG            105
  *P2rx7*        AGTCTGCAAGATGTCAAAGG          ATTTCCTCAGGTTGTCCAG           119
  *P2ry1*        ATCTCCCCCATTCTCTTCTA          TAAACCCTGTCGTTGAAATC          362
  *P2ry2*        GGCAGTTTCTGACTCTCTCT          CACTAGCACCCACACAAC            259
  *P2ry4*        ACCCGCACAATTTATTACC           TGCTGATGCTTTCCTCAT            250
  *P2ry6*        TTATCAGCTTCCTGCCTTT           GCTTCTGTAGGAGATCGTGT          210
